Longevity & AgingMay 2026 Longevity Research Roundup Brings Breakthroughs in Aging Science
The May 2026 Rejuvenation Roundup from Lifespan.io covers a wide range of longevity and aging research developments. Highlights include a successful Phase 1 trial for a cardiovascular drug targeting toxic cholesterol in plaques, new findings on creatine boosting exercise benefits in older adults, insights into how gut aging promotes harmful bacteria, and clarification that GLP-1 drugs affect muscle mass no more than regular caloric restriction. Additional coverage spans CRISPR-based cell-killing tools, mRNA cancer therapies, mitochondrial membrane lipid decline with age, cellular senescence mechanisms, and a Harvard longevity report aimed at the general public. The roundup reflects how aging biology is rapidly moving from lab research into real clinical applications.
